Fandosentan
Alternative Names: CI 1034; PD 180988; PD 180988-0016Latest Information Update: 12 Aug 2009
Price :
$50 *
At a glance
- Originator Pfizer
- Class Benzodioxoles; Heterocyclic compounds; Small molecules
- Mechanism of Action Endothelin A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Chronic obstructive pulmonary disease; Pulmonary hypertension